linkedin_logo_300x300.png
VTYX INVESTOR ALERT: Kirby McInerney LLP Alerts Ventyx Investors of Looming Lead Plaintiff Deadline in Class Action Lawsuit
April 18, 2024 17:06 ET | Kirby McInerney LLP
NEW YORK, April 18, 2024 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors of the upcoming April 30, 2024 deadline to seek the role of lead plaintiff in a federal securities...
linkedin_logo_300x300.png
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Regeneron Pharmaceuticals, Inc. (REGN)
April 18, 2024 17:03 ET | Kirby McInerney LLP
NEW YORK, April 18, 2024 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Regeneron Pharmaceuticals, Inc. (“Regeneron” or the “Company”) (NASDAQ:...
linkedin_logo_300x300.png
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Malibu Boats, Inc. (MBUU)
April 16, 2024 17:13 ET | Kirby McInerney LLP
NEW YORK, April 16, 2024 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Malibu Boats, Inc. (“Malibu” or the “Company”) (NASDAQ: MBUU). The...
linkedin_logo_300x300.png
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Zoetis Inc. (ZTS)
April 15, 2024 17:03 ET | Kirby McInerney LLP
NEW YORK, April 15, 2024 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Zoetis Inc. (“Zoetis” or the “Company”) (NYSE: ZTS). The investigation...
linkedin_logo_300x300.png
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Globe Life, Inc. (GL)
April 15, 2024 16:39 ET | Kirby McInerney LLP
NEW YORK, April 15, 2024 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Globe Life, Inc. (“Globe Life” or the “Company”) (NYSE: GL). The...
linkedin_logo_300x300.png
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against AXT, Inc. (AXTI)
April 08, 2024 17:00 ET | Kirby McInerney LLP
NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against AXT, Inc. (“AXT” or the “Company”) (NASDAQ: AXTI). The investigation...
linkedin_logo_300x300.png
Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Checkpoint Therapeutics, Inc. (CKPT) Investors
April 08, 2024 16:51 ET | Kirby McInerney LLP
NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- (GLOBENEWSWIRE)—The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Southern...
linkedin_logo_300x300.png
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Autodesk, Inc. (ADSK)
April 03, 2024 17:31 ET | Kirby McInerney LLP
NEW YORK, April 03, 2024 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Autodesk, Inc. (“Autodesk” or the “Company”) (NASDAQ:ADSK). The...
linkedin_logo_300x300.png
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Zevra Therapeutics, Inc. (ZVRA)
April 02, 2024 17:54 ET | Kirby McInerney LLP
NEW YORK, April 02, 2024 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Zevra Therapeutics, Inc. (“Zevra” or the “Company”) (NASDAQ: ZVRA). The...
linkedin_logo_300x300.png
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Zymeworks Inc. (ZYME)
April 02, 2024 17:52 ET | Kirby McInerney LLP
NEW YORK, April 02, 2024 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Zymeworks Inc. (“Zymeworks” or the “Company”) (NASDAQ: ZYME). The...